The cost of treating skeletal-related events in patients with bone metastases secondary to breast, lung, or prostate cancer

被引:0
|
作者
Barber, B. [1 ]
Oglesby, A. [1 ]
Lage, M. J. [2 ]
Harrison, D. J. [1 ]
Jun, S. [1 ]
机构
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] HealthMetr Outcomes Res LLC, Groton, CT USA
关键词
D O I
10.1016/S1098-3015(10)70227-8
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A69 / A69
页数:1
相关论文
共 50 条
  • [1] The cost of treating skeletal-related events in patients with prostate cancer
    Lage, Maureen J.
    Barber, Beth L.
    Harrison, David J.
    Jun, Sun
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (05): : 317 - 322
  • [2] The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer
    Delea, T
    Langer, C
    McKiernan, J
    Liss, M
    Edelsberg, J
    Brandman, J
    Sung, J
    Raut, M
    Oster, G
    ONCOLOGY, 2004, 67 (5-6) : 390 - 396
  • [3] The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
    Pockett, R. D.
    Castellano, D.
    McEwan, P.
    Oglesby, A.
    Barber, B. L.
    Chung, K.
    EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (06) : 755 - 760
  • [4] Statins may decrease skeletal-related events in breast cancer patients with bone metastases
    Dincer, Murat
    Bulut, Nilufer
    Harputluoglu, Hakan
    Altundag, Kadri
    MEDICAL HYPOTHESES, 2006, 67 (05) : 1146 - 1147
  • [5] Clinical and economic impact of skeletal-related events in breast cancer patients with bone metastases
    Carter, J.
    Kaura, S.
    Botteman, M.
    BREAST, 2011, 20 : S78 - S78
  • [6] COSTS OF TREATING SKELETAL-RELATED EVENTS AMONG PROSTATE CANCER PATIENTS WITH BONE METASTASES IN A COMMERCIAL INSURED POPULATION IN THE US
    Zhong, Y.
    Yao, J.
    Donga, P.
    Bilir, S. P.
    Valderrama, A.
    VALUE IN HEALTH, 2015, 18 (03) : A198 - A198
  • [7] Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases
    Hagiwara, M.
    Delea, T. E.
    Saville, M. W.
    Chung, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (01) : 23 - 27
  • [8] Bone Pain, Skeletal-Related Events and Opioid Analgesic Use in Prostate Cancer Patients with Bone Metastases
    Valderrama, Adriana
    Eapen, Sara
    Hennessey, Kelly A.
    Jones, Casey
    Wen, Lonnie
    Germino, Joseph
    Duh, Mei S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 473 - 473
  • [9] Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases
    M Hagiwara
    T E Delea
    M W Saville
    K Chung
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 23 - 27
  • [10] ZOLEDRONIC ACID IS COST EFFECTIVE FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH PROSTATE CANCER AND BONE METASTASES IN FRANCE AND GERMANY
    Meijboom, Marjan
    Botteman, Marc F.
    Kaura, Satyin
    JOURNAL OF UROLOGY, 2009, 181 (04): : 295 - 295